428 related articles for article (PubMed ID: 19246010)
1. Fumagillin and fumarranol interact with P. falciparum methionine aminopeptidase 2 and inhibit malaria parasite growth in vitro and in vivo.
Chen X; Xie S; Bhat S; Kumar N; Shapiro TA; Liu JO
Chem Biol; 2009 Feb; 16(2):193-202. PubMed ID: 19246010
[TBL] [Abstract][Full Text] [Related]
2. Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo.
Lu J; Chong CR; Hu X; Liu JO
J Med Chem; 2006 Sep; 49(19):5645-8. PubMed ID: 16970390
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess antimalarial activity.
Chen X; Chong CR; Shi L; Yoshimoto T; Sullivan DJ; Liu JO
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14548-53. PubMed ID: 16983082
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis inhibitors specific for methionine aminopeptidase 2 as drugs for malaria and leishmaniasis.
Zhang P; Nicholson DE; Bujnicki JM; Su X; Brendle JJ; Ferdig M; Kyle DE; Milhous WK; Chiang PK
J Biomed Sci; 2002; 9(1):34-40. PubMed ID: 11810023
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases.
Wang J; Lou P; Henkin J
J Cell Biochem; 2000 Apr; 77(3):465-73. PubMed ID: 10760954
[TBL] [Abstract][Full Text] [Related]
6. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2.
Griffith EC; Su Z; Niwayama S; Ramsay CA; Chang YH; Liu JO
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15183-8. PubMed ID: 9860943
[TBL] [Abstract][Full Text] [Related]
7. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2.
Sin N; Meng L; Wang MQ; Wen JJ; Bornmann WG; Crews CM
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6099-103. PubMed ID: 9177176
[TBL] [Abstract][Full Text] [Related]
8. The C. elegans methionine aminopeptidase 2 analog map-2 is required for germ cell proliferation.
Boxem M; Tsai CW; Zhang Y; Saito RM; Liu JO
FEBS Lett; 2004 Oct; 576(1-2):245-50. PubMed ID: 15474045
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.
Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH
Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007
[TBL] [Abstract][Full Text] [Related]
10. Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity.
Catalano A; Romano M; Robuffo I; Strizzi L; Procopio A
Am J Pathol; 2001 Aug; 159(2):721-31. PubMed ID: 11485930
[TBL] [Abstract][Full Text] [Related]
11. Antiparasitic activities of novel, orally available fumagillin analogs.
Arico-Muendel C; Centrella PA; Contonio BD; Morgan BA; O'Donovan G; Paradise CL; Skinner SR; Sluboski B; Svendsen JL; White KF; Debnath A; Gut J; Wilson N; McKerrow JH; DeRisi JL; Rosenthal PJ; Chiang PK
Bioorg Med Chem Lett; 2009 Sep; 19(17):5128-31. PubMed ID: 19648008
[TBL] [Abstract][Full Text] [Related]
12. Methionine aminopeptidase-2 as a selective target of myofibroblasts in pulmonary fibrosis.
Kass D; Bridges RS; Borczuk A; Greenberg S
Am J Respir Cell Mol Biol; 2007 Aug; 37(2):193-201. PubMed ID: 17446530
[TBL] [Abstract][Full Text] [Related]
13. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin.
Griffith EC; Su Z; Turk BE; Chen S; Chang YH; Wu Z; Biemann K; Liu JO
Chem Biol; 1997 Jun; 4(6):461-71. PubMed ID: 9224570
[TBL] [Abstract][Full Text] [Related]
14. Carbamate analogues of fumagillin as potent, targeted inhibitors of methionine aminopeptidase-2.
Arico-Muendel CC; Benjamin DR; Caiazzo TM; Centrella PA; Contonio BD; Cook CM; Doyle EG; Hannig G; Labenski MT; Searle LL; Lind K; Morgan BA; Olson G; Paradise CL; Self C; Skinner SR; Sluboski B; Svendsen JL; Thompson CD; Westlin W; White KF
J Med Chem; 2009 Dec; 52(24):8047-56. PubMed ID: 19929003
[TBL] [Abstract][Full Text] [Related]
15. Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis.
Zhou G; Tsai CW; Liu JO
J Med Chem; 2003 Jul; 46(16):3452-4. PubMed ID: 12877582
[TBL] [Abstract][Full Text] [Related]
16. Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: potential for drug target.
Sawanyawisuth K; Wongkham C; Pairojkul C; Saeseow OT; Riggins GJ; Araki N; Wongkham S
Acta Oncol; 2007; 46(3):378-85. PubMed ID: 17450475
[TBL] [Abstract][Full Text] [Related]
17. Methionine aminopeptidases type I and type II are essential to control cell proliferation.
Bernier SG; Taghizadeh N; Thompson CD; Westlin WF; Hannig G
J Cell Biochem; 2005 Aug; 95(6):1191-203. PubMed ID: 15962312
[TBL] [Abstract][Full Text] [Related]
18. Fumagillin suppresses HIV-1 infection of macrophages through the inhibition of Vpr activity.
Watanabe N; Nishihara Y; Yamaguchi T; Koito A; Miyoshi H; Kakeya H; Osada H
FEBS Lett; 2006 May; 580(11):2598-602. PubMed ID: 16631749
[TBL] [Abstract][Full Text] [Related]
19. Depletion of methionine aminopeptidase 2 does not alter cell response to fumagillin or bengamides.
Kim S; LaMontagne K; Sabio M; Sharma S; Versace RW; Yusuff N; Phillips PE
Cancer Res; 2004 May; 64(9):2984-7. PubMed ID: 15126329
[TBL] [Abstract][Full Text] [Related]
20. Methionine aminopeptidase 2 is a new target for the metastasis-associated protein, S100A4.
Endo H; Takenaga K; Kanno T; Satoh H; Mori S
J Biol Chem; 2002 Jul; 277(29):26396-402. PubMed ID: 11994292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
